Trial · NCT03379675
Registered outcomes40
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 40
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Area Under the Respiratory Syncytial Virus (RSV) Viral Load (VL)-Time Curve (AUC) From Immediately Prior to First Dose of Study Drug (Baseline) Through Day 3 | Baseline through Day 3 | Area under the RSV VL-time curve (AUC) was determined as log10 copies\*hour per milliliter (Log10 copies\*hr/mL) by quantitative reverse transcription polymerase chain reaction (qRT-PCR) assay of mid turbine nasal swabs. |
| Primary | Area Under the RSV VL-time Curve (AUC) From Immediately Prior to First Dose of Study Drug (Baseline) Through Day 5 | Baseline through Day 5 | Area under the RSV VL-time curve (AUC) was determined as Log10 copies\*hr/mL by qRT-PCR assay of mid turbine nasal swabs. |
| Primary | Area Under the RSV VL-time Curve (AUC) From Immediately Prior to First Dose of Study Drug (Baseline) Through Day 8 | Baseline through Day 8 | Area under the RSV VL-time curve (AUC) was determined as Log10 copies\*hr/mL by qRT-PCR assay of mid turbine nasal swabs. |
| Primary | Area Under the RSV VL-time Curve (AUC) From Immediately Prior to First Dose of Study Drug (Baseline) Through Day 14 | Baseline through Day 14 | Area under the RSV VL-time curve (AUC) was determined as Log10 copies\*hr/mL by qRT-PCR assay of mid turbine nasal swabs. |
| Primary | Change From Baseline in RSV Viral Load at Day 3 | Baseline to Day 3 | Change from baseline in RSV viral load at Day 3 was measured as Log10 copies/mL by qRT-PCR assay in the mid-turbinate nasal swab specimens. |
| Primary | Change From Baseline in RSV Viral Load at Day 5 | Baseline to Day 5 | Change from baseline in RSV viral load at Day 5 was measured as Log10 copies/mL by qRT-PCR assay in the mid-turbinate nasal swab specimens. |
| Primary | Change From Baseline in RSV Viral Load at Day 8 | Baseline to Day 8 | Change from baseline in RSV viral load at Day 8 was measured as Log10 copies/mL by qRT-PCR assay in the mid-turbinate nasal swab specimens. |
| Primary | Change From Baseline in RSV Viral Load at Day 14 | Baseline to Day 14 | Change from baseline in RSV viral load at Day 14 was measured as Log10 copies/mL by qRT-PCR assay in the mid-turbinate nasal swab specimens. |
| Primary | Change From Baseline in RSV Viral Load at Day 21 | Baseline to Day 21 | Change from baseline in RSV viral load oat Day 21 was measured as Log10 copies/mL by qRT-PCR assay in the mid-turbinate nasal swab specimens. |
| Primary | RSV Viral Load at Baseline | Baseline | RSV viral load was measured as log10 copies/mL by qRT-PCR assay in the mid-turbinate nasal swab specimens. |
| Primary | RSV Viral Load at Day 3 | Day 3 | RSV viral load was measured as log10 copies/mL by qRT-PCR assay in the mid-turbinate nasal swab specimens. |
| Primary | RSV Viral Load at Day 5 | Day 5 | RSV viral load was measured as log10 copies/mL by qRT-PCR assay in the mid-turbinate nasal swab specimens. |
| Primary | RSV Viral Load at Day 8 | Day 8 | RSV viral load was measured as log10 copies/mL by qRT-PCR assay in the mid-turbinate nasal swab specimens. |
| Primary | RSV Viral Load at Day 14 | Day 14 | RSV viral load was measured as log10 copies/mL by qRT-PCR assay in the mid-turbinate nasal swab specimens. |
| Primary | RSV Viral Load at Day 21 | Day 21 | RSV viral load was measured as log10 copies/mL by qRT-PCR assay in the mid-turbinate nasal swab specimens. |
| Primary | Time to Undetectable RSV Viral Load | Up to Day 21 | The time to undetectable nasal RSV RNA viral load was defined as the time in days from initiation of study treatment until first post-baseline time point at which RSV RNA was undetectable and after which time there were no more detectable virus assessments. |
| Primary | Percentage of Participants With Undetectable RSV Viral Load at Day 3 | Day 3 | Percentage of participants with undetectable RSV viral load at Day 3 were reported. |
| Primary | Percentage of Participants With Undetectable RSV Viral Load at Day 5 | Day 5 | Percentage of participants with undetectable RSV viral load at Day 5 were reported. |
| Primary | Percentage of Participants With Undetectable RSV Viral Load at Day 8 | Day 8 | Percentage of participants with undetectable RSV viral load at Day 8 were reported. |
| Primary | Percentage of Participants With Undetectable RSV Viral Load at Day 14 | Day 14 | Percentage of participants with undetectable RSV viral load at Day 14 were reported. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03379675/registered